(19)
(11) EP 1 988 397 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.02.2012 Bulletin 2012/07

(45) Mention of the grant of the patent:
14.09.2011 Bulletin 2011/37

(21) Application number: 08014241.7

(22) Date of filing: 19.12.2003
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
A61P 25/28(2006.01)
C07D 263/56(2006.01)
A61K 31/423(2006.01)

(54)

COMPOSITIONS AND USES FOR STABILISING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING

ZUSAMMENSETZUNGEN UND VERWENDUNGEN ZUR STABILISIERUNG VON TRANSTHYRETIN UND ZUR HEMMUNG VON TRANSTHYRETIN-FEHLFALTUNG

COMPOSITIONS ET UTILISATIONS POUR STABILISER LA TRANSTHYRETINE ET POUR INHIBER UN MAUVAIS REPLIEMENT DE LA TRANSTHYRETINE


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 19.12.2002 US 435079 P
24.04.2003 US 465435 P

(43) Date of publication of application:
05.11.2008 Bulletin 2008/45

(60) Divisional application:
10180989.5 / 2325651

(62) Application number of the earlier application in accordance with Art. 76 EPC:
03813782.4 / 1587821

(73) Proprietor: The Scripps Research Institute
La Jolla, CA 92037 (US)

(72) Inventors:
  • Kelly, Jeffery W.
    La Jolla, CA 92037 (US)
  • SEKIJIMA, Yoshiki
    Matsumoto 390-0877 (JP)

(74) Representative: Weber, Martin et al
Jones Day Prinzregentenstraße 11
80538 München
80538 München (DE)


(56) References cited: : 
   
  • PETERSON S A ET AL: "Inhibiting Transhyretin Conformational Changes That Lead To Amyloid Fibril Formation" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, vol. 95, 1 October 1998 (1998-10-01), pages 12956-12960, XP002988070 ISSN: 0027-8424
  • MIROY G J ET AL: "INHIBITING TRANSTHYRETIN AMYLOID FIBRIL FORMATION VIA PROTEIN STABILIZATION" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, vol. 93, no. 26, 1 December 1996 (1996-12-01), pages 15051-15056, XP002070247 ISSN: 0027-8424
  • KELLEY J W: "The Environment Dependency of Protein Folding Best Explains Prion and Amyloid Diseases" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, vol. 95, 1 February 1998 (1998-02-01), pages 930-932, XP002988069 ISSN: 0027-8424
  • LASHUEL H A ET AL: "New Class Of Inhibitors Of Amyloid-beta Fibril Formation" JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,; US, vol. 277, no. 45, 1 November 2002 (2002-11-01), pages 42881-42890, XP002988068 ISSN: 0021-9258
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).